Low rate of subclinical venous thrombosis in patients with haemophilia undergoing major orthopaedic surgery in the absence of pharmacological thromboprophylaxis. 2020

Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

BACKGROUND Deep venous thrombosis (DVT) is a common postoperative complication in patients undergoing major orthopaedic surgery of the lower limbs, such as total hip or knee replacement (THR, TKR). Routine pharmacological thromboprophylaxis with low-molecular-weight heparin (LMWH) or a direct oral anticoagulant agent is strongly recommended in this setting. THR and TKR as well as ankle arthrodesis are frequently performed in people with haemophilia (PWH) and chronic haemophilic arthropathy. Pharmacological thromboprophylaxis in this population remains controversial. METHODS We report the results of a single-centre prospective study initiated in 2002 evaluating by systematic Doppler ultrasound the incidence of subclinical DVT in consecutive PWH referred for major orthopaedic surgery and not receiving pharmacological thromboprophylaxis. RESULTS We included 46 different PWH (39 Haemophilia A, 7 Haemophilia B, 27 severe, 15 moderate and 4 mild forms) undergoing 67 orthopaedic procedures. Most (89.5%) were performed with continuous infusion of clotting factor concentrates. Rehabilitation was usually started on day 1 post-op. No clinical DVT or pulmonary embolism was suspected. In total, there were 5 cases (3 severe, 1 moderate HA and 1 moderate HB) of subclinical DVT which were all distal. Two patients were treated with a short course (10-14 days) of LMWH. The overall incidence of DVT was 7.5%. CONCLUSIONS These data provide imaging-based evidence that the risk of DVT following major orthopaedic surgery among PWH is low. Identified DVTs were distal and resolved spontaneously in most cases. Systematic pharmacological thromboprophylaxis in this specific population is probably for most patients not required.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
April 2024, Haemophilia : the official journal of the World Federation of Hemophilia,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
June 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
January 2008, Drugs & aging,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
November 2009, Haemophilia : the official journal of the World Federation of Hemophilia,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
November 2009, Haemophilia : the official journal of the World Federation of Hemophilia,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
July 2016, Thrombosis and haemostasis,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
May 2010, Journal of thrombosis and haemostasis : JTH,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
January 1989, British journal of clinical practice. Supplement,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
January 1990, Acta chirurgica Scandinavica. Supplementum,
Géraldine Verstraete, and Catherine Lambert, and Frank Hammer, and Cedric Hermans
December 2022, Diagnostics (Basel, Switzerland),
Copied contents to your clipboard!